The critical 340B program, designed to ensure discounted drugs to vulnerable healthcare organizations, is facing heightened examination by various parties. Issues revolve around possible diversion of funds and whether https://340bdrugpricingprogram044756.blog5.net/98361742/the-current-340b-initiative-under-examination-what-s-in-jeopardy